Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-A02303741:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BLOC1S4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | MEAF6 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SGSM1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ARHGEF10L | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ATP9B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ZNF385C | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | WDR61 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | FKBP2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | C1D | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | UMOD | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |